Montpellier

France

269 total trials 130 recruiting

Filter these 269 trials by phase, condition, sponsor and more.

Open in Search →

The Late Presenter Treatment Optimisation Study (LAPTOP) Ended

2023-505167-36-00 5 2019-08-05 Patients who present late on during their acquisition of the HIV-1 (Hu
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 5 2019-05-24 Adults at high risk of cardiovascular events without prior MI or strok
A Study of Nivolumab and Ipilimumab Combined with Chemotherapy Compared to Chemotherapy by Itself as the First Treatment Given for Stage IV … Ended

2023-508757-75-00 5 2017-09-18 Stage IV Non-Small Cell Lung Cancer (NSCLC)
PRODIGE 76-IMMUNOBILADJ: Capecitabine plus durvalumab or capecitabine alone as adjuvant therapy in patients with resected biliary tract carc … Ended

2023-503807-27-00 4 Biliary tract carcinoma
Randomized Phase II Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab in Locally Advanc … Ended

2024-515533-15-00 4 Locally advanced cervical cancer

Showing 265–269 of 269 trials